Healthcare -
Biotechnology - NASDAQ - US
$ 1.8267
-4.86 %
$ 19.6 M
Market Cap
-1.71
P/E
MRKR - OPERATING INCOME
Operating Income MRKR - Marker Therapeutics, Inc.
-14.6 M
LAST VALUE
39.23%
2 YEAR CAGR
37.11%
5 YEAR CAGR
-15.98%
10 YEAR CAGR